Research institute
Their work has helped in the development of new medications to fight anemia, cancer and many other diseases.
The drug is called BOS172722 and it forces cancer cells to multiply faster, which would seem to be counterintuitive. However, this faster cell division causes more fatal errors in the cells.
This institute will focus on educating and training URI’s nursing and pharmacy students, faculty and staff in immuno-oncology.
Phase III trial validates the benefit of veliparib for patients without a BRCA mutation
A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings reveal.
We’re proud to announce the launch of the Research on Research Institute – an international consortium of research funders, academic institutions, and technologists working to champion the latest approaches to research on research.
Regenstrief Institute research scientist Daniel Bateman, M.D., receives federal award to study technological intervention
The UC Santa Cruz Genomics Institute will play a leading role in the ambitious new Human Pangenome Reference Sequence Project
Research from the Wellcome Sanger Institute, GSK and Biogen, under the Open Targets initiative, has shown that thousands of differences in DNA between individuals, associated with immune diseases, are linked with the switching-on of a specific subtype of immune cells.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
PRESS RELEASES